Biotech Stock

Peregrine Pharmaceuticals, Inc

Conduct and Ethics. The Board of Directors (the "Board") of the Company adopted the corporate governance policies and charters. Copies of the following corporate governance documents are posted on our website, and are available free of charge, at www.peregrineinc.com : (1) Peregrine Pharmaceuticals, Inc. Code of Business Conduct and Ethics ... more

Blockbuster, Inc.

Opportunity Ventures” and state laws and regulations that govern the offer and sale of franchises and franchise relationships. If we want to offer and sell a franchise, we are required to furnish to each prospective franchisee a current franchise offering circular prior to the offer or sale of a franchise. In addition, a number of states require us to comply with registration or filing ... more

Genelabs Technology

Genelabs Technologies, Inc., referred to as Genelabs or the Company, is a biopharmaceutical company engaged in the discovery and development of pharmaceutical products to improve human health. Our business objective is to develop a competitive advantage by focusing on drug targets for which we can rapidly optimize lead compounds, with the goal of developing drugs with ... more

Regeneron Pharmaceuticals Cp

This Annual Report on Form 10-K contains forward-looking statements that involve risks and uncertainties relating to future events and the future financial performance of Regeneron Pharmaceuticals, Inc., and actual events or results may differ materially. These statements concern, among other things, the possible success and therapeutic applications of ... more

Geovax Labs, Inc

- Previous Operations"). Included in those operations was Suncoast Automation, Inc., which the Company sold on April 28, 2003. We were unsuccessful in generating income from or positive cash flow from any of our operations, including Suncoast's operations. Our operations in Greece and Suncoast operations have been included and presented as "Discontinued Operations" in this ... more

Momenta Pharmaceuticals, Inc

We have incurred significant losses since our inception in May 2001. At December 31, 2006, our accumulated deficit was approximately $125.5 million. We have not generated revenues from the sale of any products to date. We expect that our annual operating losses will increase over the next several years as we expand our drug commercialization, development and discovery efforts. To ... more

United Therapeutics

The company develops therapeutic products for patient with chronic and life-threatening cardiovascular, cancer, and infectious diseases. It also offers telemedicine services for detection of cardiac arrhythmias and ischemic heart disease. more

Ariad Pharmaceuticals

We are a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. As with all scientific endeavors, we face much trial and error, and we may fail at numerous stages along the way, which would inhibit us from successfully developing, ... more

Gtc Biotherapeut

We have had operating losses since our inception, and we expect losses to continue for the next several years. From our inception in 1993 to December 31, 2006, we have incurred cumulative losses of approximately $245 million. These losses have resulted principally from the costs of our research and development activities. Our net losses for fiscal years 2004, 2005 and 2006, have been ... more

Perkinelmer, Inc.

We are a leading provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, academic research, environmental testing and general industrial markets, commonly referred to as the health sciences and photonics markets. We design, manufacture, market and service products and systems within two businesses, each constituting a separate reporting segment: more

Stockgroup Information Systems Inc.

Stockgroup Information Systems Inc. provides financial information and web-based portfolio management services. The company operates online through Stockhouse.com website. more

Neurobiological Technologs, Inc

Statements in this Business section and other parts of this Annual Report on Form 10-KSB that are not historical are forward-looking statements and are subject to a number of risks and uncertainties which could cause actual results to differ materially from those discussed in the forward-looking statements. Factors that might cause such a difference include, but are not ... more

Siga Tech, Inc

Certain statements in this Annual Report on Form 10-KSB, including certain statements contained in "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations," constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The ... more

Millipore Corporation

Millipore is a global life science company that provides technologies, tools and services facilitating the discovery, development and production of new therapeutic drugs, vaccines and detection tools, together with other applications. We serve the worldwide biotechnology, pharmaceutical and life science research industries by improving productivity and efficiency. We primarily sell consumable ... more

Martek Biosciences Corp

Development, a role he filled until his election to President of Martek in September 2003. He also spent time during 2000 through 2003 co-founding and co-managing a Maryland-based, angel-investing club that funds early-stage, high-potential businesses. He was also “Of Counsel” to the law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. during part of 2001 and 2002. Prior ... more